

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.60817818 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.60817818 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.39364246 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.19766219 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.93118809 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.81988010 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.42153468 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.06863449 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.81127723 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.81127723 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.81127723 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.81127723 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.81127723 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.81127723 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.77821826 |
| 16 | leukocyte aggregation (GO:0070486) | 4.73955631 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.71132711 |
| 18 | detection of bacterium (GO:0016045) | 4.63522965 |
| 19 | detection of other organism (GO:0098543) | 4.63490165 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.60598278 |
| 21 | negative T cell selection (GO:0043383) | 4.51409946 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.48803866 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.47184691 |
| 24 | positive thymic T cell selection (GO:0045059) | 4.32457013 |
| 25 | response to interleukin-15 (GO:0070672) | 4.19735859 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.18373515 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.05039358 |
| 28 | cellular extravasation (GO:0045123) | 4.02996327 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 4.00560349 |
| 30 | T cell selection (GO:0045058) | 3.91553614 |
| 31 | thymic T cell selection (GO:0045061) | 3.89819965 |
| 32 | response to peptidoglycan (GO:0032494) | 3.88699119 |
| 33 | positive T cell selection (GO:0043368) | 3.87243958 |
| 34 | T cell migration (GO:0072678) | 3.86779964 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.85243003 |
| 36 | tolerance induction (GO:0002507) | 3.84331971 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.83103053 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.81728470 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.78620717 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.78246262 |
| 41 | regulation of B cell differentiation (GO:0045577) | 3.75271143 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.75112980 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.74657913 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 3.72780161 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.70336642 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.70306960 |
| 47 | respiratory burst (GO:0045730) | 3.68126806 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.64072931 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57133407 |
| 50 | neutrophil activation (GO:0042119) | 3.54428707 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.50880144 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.45936466 |
| 53 | activated T cell proliferation (GO:0050798) | 3.43079274 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.42618071 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.41692162 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.41692162 |
| 57 | response to type I interferon (GO:0034340) | 3.40495170 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39101504 |
| 59 | negative regulation of phagocytosis (GO:0050765) | 3.38245223 |
| 60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.37672903 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.35491546 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.34583913 |
| 63 | granulocyte activation (GO:0036230) | 3.23441186 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22883028 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22752446 |
| 66 | response to host immune response (GO:0052572) | 3.22752446 |
| 67 | defense response to protozoan (GO:0042832) | 3.22567418 |
| 68 | germinal center formation (GO:0002467) | 3.20529902 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.19261930 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.17076862 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.17076862 |
| 72 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16717768 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12266187 |
| 74 | negative regulation of innate immune response (GO:0045824) | 3.09582837 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.08960608 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08254122 |
| 77 | leukocyte degranulation (GO:0043299) | 3.06365845 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05132851 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.04921510 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02685089 |
| 81 | response to host (GO:0075136) | 3.02685089 |
| 82 | response to host defenses (GO:0052200) | 3.02685089 |
| 83 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.01735472 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00986619 |
| 85 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00986619 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 3.00855657 |
| 87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00442185 |
| 88 | B cell mediated immunity (GO:0019724) | 2.99226412 |
| 89 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.98934592 |
| 90 | microglial cell activation (GO:0001774) | 2.97670283 |
| 91 | T cell homeostasis (GO:0043029) | 2.97583422 |
| 92 | response to protozoan (GO:0001562) | 2.96234871 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.95602983 |
| 94 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.95120556 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93035602 |
| 96 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92500461 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 2.90521161 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.89779767 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 2.89306982 |
| 100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87320078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17823279 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.19732890 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.63691070 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53380291 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41709577 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.32283238 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31046535 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.25180215 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88995294 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86505257 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.74492269 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.74482780 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63466523 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63371640 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.61186791 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60251525 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55511678 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.53620213 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53530034 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.52354913 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.48564067 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44536534 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43317832 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.41200399 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39680149 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36788836 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34829398 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.32048226 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.31874491 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31809684 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26894540 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26225676 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23493816 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 2.17741354 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11541551 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.10864899 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10666440 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09136418 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.07445827 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.99044969 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91141131 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87983002 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74941212 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67900850 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65534510 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57378080 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57327033 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.56080631 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53161770 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51229827 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51094667 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48104330 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47429279 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47060733 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43701363 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43386217 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39922579 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38418346 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38076910 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32219422 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32042811 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30869798 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30249919 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27366503 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27346578 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27024962 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26880833 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26310956 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24712384 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24501323 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22345707 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21981305 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20834858 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20613983 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19622927 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19117678 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15899684 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14468618 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14385705 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12842517 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11624722 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11299050 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10601050 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08557614 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07372931 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07052714 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03144947 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01924275 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00876252 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00849829 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00749970 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99821939 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99666697 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97326341 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95049624 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.93747166 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92493536 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89845174 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86144222 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83455870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.23592364 |
| 2 | MP0003724_increased_susceptibility_to | 3.91352764 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.76408591 |
| 4 | MP0003303_peritoneal_inflammation | 3.45934519 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.38027755 |
| 6 | MP0005671_abnormal_response_to | 3.30973623 |
| 7 | MP0001800_abnormal_humoral_immune | 3.22557489 |
| 8 | MP0005387_immune_system_phenotype | 3.02565958 |
| 9 | MP0001790_abnormal_immune_system | 3.02565958 |
| 10 | MP0000685_abnormal_immune_system | 3.01302068 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.97645294 |
| 12 | MP0002419_abnormal_innate_immunity | 2.91478680 |
| 13 | MP0005025_abnormal_response_to | 2.83896886 |
| 14 | MP0002723_abnormal_immune_serum | 2.73981326 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.72451805 |
| 16 | MP0001819_abnormal_immune_cell | 2.69273841 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.66023918 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.56352326 |
| 19 | MP0009785_altered_susceptibility_to | 2.51074914 |
| 20 | MP0006082_CNS_inflammation | 2.39876700 |
| 21 | MP0002398_abnormal_bone_marrow | 2.27885466 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.16528220 |
| 23 | MP0002405_respiratory_system_inflammati | 2.16496291 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.16147625 |
| 25 | MP0000716_abnormal_immune_system | 2.13658850 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.13489033 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.00725917 |
| 28 | MP0002396_abnormal_hematopoietic_system | 2.00673319 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.95239059 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.91936914 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.89670155 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.89537291 |
| 33 | MP0004947_skin_inflammation | 1.86509205 |
| 34 | MP0002722_abnormal_immune_system | 1.86238330 |
| 35 | MP0009278_abnormal_bone_marrow | 1.77737219 |
| 36 | MP0008260_abnormal_autophagy | 1.76629453 |
| 37 | MP0003866_abnormal_defecation | 1.74663805 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.74043371 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.73153380 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.72073092 |
| 41 | MP0002429_abnormal_blood_cell | 1.71866891 |
| 42 | MP0001873_stomach_inflammation | 1.62145085 |
| 43 | MP0004381_abnormal_hair_follicle | 1.55272589 |
| 44 | MP0005310_abnormal_salivary_gland | 1.52805275 |
| 45 | MP0002132_abnormal_respiratory_system | 1.47360350 |
| 46 | MP0005451_abnormal_body_composition | 1.44720329 |
| 47 | MP0001851_eye_inflammation | 1.44486615 |
| 48 | MP0003828_pulmonary_edema | 1.44153008 |
| 49 | MP0008469_abnormal_protein_level | 1.38375022 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.29813781 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.28619734 |
| 52 | MP0000858_altered_metastatic_potential | 1.28404222 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.25854846 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.22091592 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.22091592 |
| 56 | MP0004510_myositis | 1.21760530 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.21028118 |
| 58 | MP0002933_joint_inflammation | 1.11881971 |
| 59 | MP0009764_decreased_sensitivity_to | 1.10471224 |
| 60 | MP0001853_heart_inflammation | 1.09465766 |
| 61 | MP0004883_abnormal_blood_vessel | 1.08823910 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.08550347 |
| 63 | MP0002009_preneoplasia | 1.05698645 |
| 64 | MP0000490_abnormal_crypts_of | 1.04693350 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.02533000 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.02137063 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 0.96151770 |
| 68 | MP0001663_abnormal_digestive_system | 0.92814793 |
| 69 | MP0003690_abnormal_glial_cell | 0.85450772 |
| 70 | MP0001986_abnormal_taste_sensitivity | 0.85213986 |
| 71 | MP0005166_decreased_susceptibility_to | 0.83260496 |
| 72 | MP0003075_altered_response_to | 0.81118068 |
| 73 | MP0003448_altered_tumor_morphology | 0.78695767 |
| 74 | MP0009763_increased_sensitivity_to | 0.77704605 |
| 75 | MP0002006_tumorigenesis | 0.76380513 |
| 76 | MP0005390_skeleton_phenotype | 0.76165551 |
| 77 | MP0008004_abnormal_stomach_pH | 0.75446923 |
| 78 | MP0005164_abnormal_response_to | 0.72026237 |
| 79 | MP0009840_abnormal_foam_cell | 0.68988762 |
| 80 | MP0000604_amyloidosis | 0.68468730 |
| 81 | MP0002019_abnormal_tumor_incidence | 0.67997155 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.67830138 |
| 83 | MP0003091_abnormal_cell_migration | 0.67164843 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.64503407 |
| 85 | MP0000249_abnormal_blood_vessel | 0.63958531 |
| 86 | MP0004130_abnormal_muscle_cell | 0.63173821 |
| 87 | MP0003795_abnormal_bone_structure | 0.62302888 |
| 88 | MP0003045_fibrosis | 0.61707514 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.60851256 |
| 90 | MP0008874_decreased_physiological_sensi | 0.59450145 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.58839876 |
| 92 | MP0000343_altered_response_to | 0.57081835 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.51477533 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.49456048 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.48427850 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.48147647 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.46734507 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.45993831 |
| 99 | MP0000609_abnormal_liver_physiology | 0.44670329 |
| 100 | MP0009115_abnormal_fat_cell | 0.42135338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.68201040 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.52007726 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.49758461 |
| 4 | Myositis (HP:0100614) | 5.14186901 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.96659479 |
| 6 | Stomatitis (HP:0010280) | 4.69868198 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59651151 |
| 8 | Orchitis (HP:0100796) | 4.46013699 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.40965028 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.39695314 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.29320117 |
| 12 | Optic neuritis (HP:0100653) | 4.24325912 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.24325912 |
| 14 | Meningitis (HP:0001287) | 4.22824670 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.16457422 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.96899630 |
| 17 | Obstructive lung disease (HP:0006536) | 3.96899630 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.90751603 |
| 19 | Increased IgE level (HP:0003212) | 3.81959361 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.81498014 |
| 21 | Recurrent skin infections (HP:0001581) | 3.75204527 |
| 22 | Pustule (HP:0200039) | 3.73609790 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.64754423 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.64754423 |
| 25 | Encephalitis (HP:0002383) | 3.64413126 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.63946505 |
| 27 | T lymphocytopenia (HP:0005403) | 3.62069890 |
| 28 | Vasculitis (HP:0002633) | 3.58325042 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.55659176 |
| 30 | Cellulitis (HP:0100658) | 3.48517816 |
| 31 | Recurrent viral infections (HP:0004429) | 3.47289281 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.38895946 |
| 33 | Inflammation of the large intestine (HP:0002037) | 3.32414533 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 3.29761448 |
| 35 | Gingivitis (HP:0000230) | 3.20237891 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.16189687 |
| 37 | Abnormality of T cells (HP:0002843) | 3.15918678 |
| 38 | Chest pain (HP:0100749) | 3.10233083 |
| 39 | Urticaria (HP:0001025) | 3.09277679 |
| 40 | Colitis (HP:0002583) | 3.07249829 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 3.04944068 |
| 42 | Lymphopenia (HP:0001888) | 3.02147593 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.91697678 |
| 44 | Hypochromic anemia (HP:0001931) | 2.90897598 |
| 45 | Granulocytopenia (HP:0001913) | 2.90306646 |
| 46 | Epistaxis (HP:0000421) | 2.86398011 |
| 47 | Leukocytosis (HP:0001974) | 2.83247401 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.82096557 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.80814851 |
| 50 | IgM deficiency (HP:0002850) | 2.78853688 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.77351189 |
| 52 | Hemoptysis (HP:0002105) | 2.75084698 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.71933968 |
| 54 | Osteomyelitis (HP:0002754) | 2.66746560 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.63357538 |
| 56 | Increased IgM level (HP:0003496) | 2.62989932 |
| 57 | Papilloma (HP:0012740) | 2.59749079 |
| 58 | Verrucae (HP:0200043) | 2.59749079 |
| 59 | Petechiae (HP:0000967) | 2.55942107 |
| 60 | Gingival bleeding (HP:0000225) | 2.54828655 |
| 61 | Episodic fever (HP:0001954) | 2.49980457 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.46097867 |
| 63 | Pulmonary embolism (HP:0002204) | 2.43711379 |
| 64 | Sepsis (HP:0100806) | 2.41783448 |
| 65 | Arterial thrombosis (HP:0004420) | 2.37456373 |
| 66 | Anorexia (HP:0002039) | 2.30339955 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.29365471 |
| 68 | Autoimmune hemolytic anemia (HP:0001890) | 2.29343104 |
| 69 | Eosinophilia (HP:0001880) | 2.28624967 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.24778576 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24294151 |
| 72 | Viral hepatitis (HP:0006562) | 2.22112331 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.20633093 |
| 74 | Purpura (HP:0000979) | 2.18738743 |
| 75 | Microcytic anemia (HP:0001935) | 2.17054483 |
| 76 | Slow saccadic eye movements (HP:0000514) | 2.16336227 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.12892112 |
| 78 | Skin ulcer (HP:0200042) | 2.12152904 |
| 79 | Abnormality of the fingertips (HP:0001211) | 2.11457129 |
| 80 | Restrictive lung disease (HP:0002091) | 2.09605798 |
| 81 | Papilledema (HP:0001085) | 2.07378598 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.05461922 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.03607743 |
| 84 | IgG deficiency (HP:0004315) | 2.00437484 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.00252217 |
| 86 | Abnormal platelet volume (HP:0011876) | 1.98583801 |
| 87 | Chronic otitis media (HP:0000389) | 1.97877328 |
| 88 | Increased serum ferritin (HP:0003281) | 1.96503374 |
| 89 | Recurrent pneumonia (HP:0006532) | 1.96458739 |
| 90 | Hepatosplenomegaly (HP:0001433) | 1.95863278 |
| 91 | Amyloidosis (HP:0011034) | 1.95808897 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 1.95758540 |
| 93 | Glomerulopathy (HP:0100820) | 1.94037000 |
| 94 | Gangrene (HP:0100758) | 1.93883596 |
| 95 | Loss of speech (HP:0002371) | 1.92238312 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 1.89176134 |
| 97 | Combined immunodeficiency (HP:0005387) | 1.88277929 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87974771 |
| 99 | Skin rash (HP:0000988) | 1.86752371 |
| 100 | Acute hepatic failure (HP:0006554) | 1.85912664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.62880026 |
| 2 | RIPK4 | 4.13409766 |
| 3 | PRPF4B | 3.24317582 |
| 4 | TYK2 | 2.75392848 |
| 5 | BLK | 2.68176152 |
| 6 | ERN1 | 2.65702831 |
| 7 | IRAK4 | 2.52744824 |
| 8 | FES | 2.49980733 |
| 9 | MAP2K3 | 2.38818974 |
| 10 | GRK6 | 2.36902169 |
| 11 | TNK2 | 2.32335437 |
| 12 | CSK | 2.25908970 |
| 13 | TXK | 2.17293298 |
| 14 | ZAP70 | 2.15251955 |
| 15 | BTK | 2.06663677 |
| 16 | MAP3K13 | 1.90474530 |
| 17 | MAP3K14 | 1.82538602 |
| 18 | JAK3 | 1.81429837 |
| 19 | SYK | 1.77418194 |
| 20 | IKBKE | 1.74946554 |
| 21 | HCK | 1.69623550 |
| 22 | SIK3 | 1.60857675 |
| 23 | EPHB1 | 1.56463827 |
| 24 | TBK1 | 1.53201344 |
| 25 | TRIB3 | 1.46858798 |
| 26 | ITK | 1.46564515 |
| 27 | TAOK1 | 1.45707719 |
| 28 | JAK1 | 1.44213713 |
| 29 | MAP3K3 | 1.38168013 |
| 30 | MAP3K10 | 1.35759822 |
| 31 | LCK | 1.35604434 |
| 32 | MAP3K11 | 1.35554482 |
| 33 | LYN | 1.33903474 |
| 34 | TAOK3 | 1.32918508 |
| 35 | SIK2 | 1.28307479 |
| 36 | CSF1R | 1.27805965 |
| 37 | FGR | 1.26952106 |
| 38 | SMG1 | 1.24432525 |
| 39 | MARK3 | 1.18321414 |
| 40 | JAK2 | 1.14691580 |
| 41 | MARK2 | 1.11683185 |
| 42 | TEC | 1.11519587 |
| 43 | MAP3K1 | 1.11013898 |
| 44 | KIT | 1.10065678 |
| 45 | IKBKB | 1.04180545 |
| 46 | FGFR4 | 0.98102916 |
| 47 | STK10 | 0.94315682 |
| 48 | PRKD2 | 0.91524006 |
| 49 | TESK2 | 0.89844185 |
| 50 | SIK1 | 0.89294257 |
| 51 | KSR2 | 0.88754472 |
| 52 | PDK1 | 0.88602497 |
| 53 | MAPK12 | 0.83826431 |
| 54 | TAOK2 | 0.82303131 |
| 55 | MAP3K7 | 0.81707899 |
| 56 | CDC42BPA | 0.79584443 |
| 57 | YES1 | 0.78918870 |
| 58 | HIPK2 | 0.78633977 |
| 59 | CDK12 | 0.78489399 |
| 60 | PTK6 | 0.77769345 |
| 61 | PASK | 0.75291752 |
| 62 | NLK | 0.75046022 |
| 63 | CAMKK1 | 0.74775006 |
| 64 | FGFR3 | 0.73712889 |
| 65 | PRKCQ | 0.72677757 |
| 66 | MAPK7 | 0.72445469 |
| 67 | CDK4 | 0.69314393 |
| 68 | BMPR2 | 0.67312281 |
| 69 | PIM1 | 0.66182461 |
| 70 | PDPK1 | 0.65421527 |
| 71 | IRAK1 | 0.62107225 |
| 72 | FYN | 0.59506093 |
| 73 | LRRK2 | 0.59453936 |
| 74 | IRAK2 | 0.58550841 |
| 75 | CAMKK2 | 0.56322785 |
| 76 | TGFBR2 | 0.53969328 |
| 77 | RPS6KL1 | 0.51320114 |
| 78 | RPS6KC1 | 0.51320114 |
| 79 | MAP2K2 | 0.51184417 |
| 80 | DYRK1B | 0.50558862 |
| 81 | CDK19 | 0.49260337 |
| 82 | MATK | 0.49064511 |
| 83 | MAPK11 | 0.47610576 |
| 84 | STK11 | 0.44228708 |
| 85 | CDK6 | 0.42698984 |
| 86 | RET | 0.42352769 |
| 87 | RPS6KA6 | 0.42041399 |
| 88 | SGK3 | 0.40377366 |
| 89 | MAP3K6 | 0.37824410 |
| 90 | PIK3CG | 0.36828228 |
| 91 | PTK2B | 0.35336091 |
| 92 | PRKCH | 0.34165302 |
| 93 | STK38 | 0.33902075 |
| 94 | PKN2 | 0.33496186 |
| 95 | MELK | 0.32366372 |
| 96 | MAPKAPK2 | 0.32262509 |
| 97 | MAPK4 | 0.29124885 |
| 98 | BMX | 0.28836014 |
| 99 | MAP3K5 | 0.28257768 |
| 100 | MAP3K8 | 0.27669611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.02230824 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73906352 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.73472758 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70508522 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67607376 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58200642 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.57680495 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35486850 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.29199076 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.10351332 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97849080 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97589457 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.96994114 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91987858 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87780226 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84418853 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.83367332 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82229628 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81496210 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.80257240 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77846114 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76060407 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.71697621 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58835997 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57937171 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.57192727 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54934858 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53893874 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52786584 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51274158 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.49540188 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.45078050 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38412155 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35263196 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25740330 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.24155600 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21096892 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20051358 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18326503 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.16085088 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11392076 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09156487 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.06697172 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04406453 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.04227631 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.01770620 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97146735 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.96466247 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91931791 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91027773 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89767947 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.87724143 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.86425688 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84732752 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84418713 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83421163 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81900752 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81417713 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80467220 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79855979 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79498902 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79426655 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77684473 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76827281 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75008666 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73562944 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73373973 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72751594 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70101552 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.70091758 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68800774 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.67568160 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66901657 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65873178 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63753540 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63143559 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.63033839 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57557384 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57254608 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51141465 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50941285 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50470379 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49973821 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.49778833 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49719555 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49637549 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48434849 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.46817997 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46789560 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43862682 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42955488 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41254244 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38254574 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38066248 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36959045 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.36227407 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35792374 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34845880 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.33027201 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32980369 |

